The Traderszone Network

Published in TZ Latest News 4 December, 2015 by The TZ Newswire Staff

Insider Selling Caused Ziopharm Oncology to Drop 15%

Chief Operating Officer Caesar Belbel exercised options and sold shares worth nearly $2 million.